Cassava Sciences Inc
Change company Symbol lookup
Select an option...
SAVA Cassava Sciences Inc
AQUI Aquagold International Inc
AIG American International Group Inc
OII Oceaneering International Inc
ACQRU Independence Holdings Corp
IFPJF Informa PLC
FKWL Franklin Wireless Corp
VTI.IV Vanguard Total Stock Market ETF
$NQUSL40501010AUDT Nasdaq US Large Cap Airlines Total R
VLO Valero Energy Corp
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimers brain. The SavaDx, is an early-stage program focused on detecting the presence of Alzheimers disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is also developing SavaDx is a quantitative blood-based investigational biomarker/diagnostic to detect and monitor Alzheimer's disease. The Company’s scientific approach for the treatment of Alzheimers disease seeks to simultaneously progress both neurodegeneration and neuroinflammation.

Closing Price
$48.51
Day's Change
4.56 (10.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
48.76
Day's Low
43.11
Volume
(Light)
Volume:
6,059,526

10-day average volume:
8,520,499
6,059,526
  • Prev Close
    43.95
  • Today's Open
    43.97
  • Day's Range
    43.11-48.76
  • Avg Vol (10-day)
    8.5M
  • Last (time)
    4:00p ET 09/17/21
  • Last (size)
    5
  • 52-Wk Range
    6.70 - 146.16
    LowHigh
  • (12/29/20 - 07/29/21)
    624.03%
  • 176.4%
  • Market Cap
    1.9B
  • Shares Outstanding
    40.0M
  • -0.37
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 25.60
  • (% of float 08/31/21)
    21.11

Latest News

September 18, 2021
4:45 pm ET
Globe Newswire
9:33 am ET
Globe Newswire
8:04 am ET
Newsfile
September 17, 2021
4:58 pm ET
Newsfile
4:31 pm ET
Newsfile
3:10 pm ET
Accesswire
2:15 pm ET
Accesswire
1:25 pm ET
Newsfile
1:25 pm ET
Accesswire
1:00 pm ET
Globe Newswire
11:35 am ET
Accesswire
11:01 am ET
Accesswire
9:46 am ET
Accesswire
8:55 am ET
Accesswire
6:00 am ET
Accesswire
September 16, 2021
5:55 pm ET
Newsfile
5:16 pm ET
Newsfile
12:18 pm ET
Accesswire
11:30 am ET
PR Newswire
10:36 am ET
PR Newswire
9:45 am ET
Accesswire
9:01 am ET
Accesswire
September 15, 2021
11:05 pm ET
Accesswire
8:57 pm ET
Globe Newswire
7:48 pm ET
Accesswire
5:41 pm ET
Newsfile
2:56 pm ET
Accesswire
1:02 pm ET
Newsfile
12:45 pm ET
Globe Newswire
11:18 am ET
Newsfile
10:44 am ET
Newsfile
5:40 am ET
Newsfile
September 14, 2021
8:44 pm ET
Newsfile
7:16 pm ET
Newsfile
6:13 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.